The evaluation for safety and usefulness of the robotic assisted laparoscopic total or radical hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy

The evaluation for safety and usefulness of the robotic assisted laparoscopic total or radical hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy - The evaluation for safety and usefulness of the robotic surgery for uterine cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011374

Enrollment

Registered

2013-08-05

Start date

2013-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine cervical or corpus cancer

Interventions

Robotic assisted laparoscopic total or radical hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy Abdominal total or radical hysterectomy with bilateral salpingo-oophorectomy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Low-recurrent risk uterine corpus cancer (FIGO IA and endometrioid adenocarcinoma, G1 or G2) that requires surgery or uterine cervical cancer (FIGO IA2 or IB1)

Exclusion criteria

Exclusion criteria: Inappropriate cases for laparoscopic surgeries due to severe endometriosis, large uterine leiomyoma, severe obesity, severe intraabdominal adhesion and other factors

Design outcomes

Primary

Measure	Time frame
Operation time, blood loss, the number of lymph nodes, complications, postsurgical pain, hemoglobin concentration, the levels of serum CRP	—

Countries

Japan

Contacts

Public ContactAkira Iwase

Nagoya University Graduate School of Medicine Department of Obstetrics and Gynecology

akiwase@med.nagoya-u.ac.jp052-744-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026